SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Neurobiological Tech (NTII)
An SI Board Since September 1996
Posts SubjectMarks Bans Symbol
1494 40 0 NTII
Emcee:  Miles Rhyne Hoffman, CFA Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
769 NTII is over $7 per share and on the move. There is no news. The news that I exDr. John M. de Castro-2/9/2000
768 Patient Enrollment Completed in Phase II Trial of Memantine for Treatment Of DeDr. John M. de Castro-1/31/2000
767 Medscape ...... (Sorry in advance if this has already been posted here. Old agJohn McCarthy-1/30/2000
766 I concur with Dr. Tracy. It is my understanding that patient enrollment is compDr. John M. de Castro-1/26/2000
765 There has been no press release of late because there has not been anything subNeuroInvestment-1/25/2000
764 AIDS DEMENTIA TREATMENTS Hi Cheryl - Thank you for your post. I was unaware John McCarthy-1/25/2000
763 John, I've read most of the articles you cited. I've just begun lookinCheryl Galt-1/25/2000
762 John, You might have provided the answer to my question regarding the word getCraig S. Owens-1/24/2000
761 Diabetic Neuropathy ....... Some articles from MedScape ....... medscape.com John McCarthy-1/23/2000
760 John - Thanks for laying out the P3 scenario. As an FYI, the NTII press releaJohn McCarthy-1/23/2000
759 I don't expect NTII to initiate a Phase III trial without a partner. The coDr. John M. de Castro-1/21/2000
758 I think the word is getting out on old NTI. I'm sitting here at work just aCraig S. Owens-1/21/2000
757 What sort of time schedule for Phase III and final marketing can we expect? John Q Binford-1/20/2000
756 There are some pretty good estimates of the "*"s in the document. HarDr. John M. de Castro-1/20/2000
755 Hi John ....... Thank you for posting the P2 results for Memantine. This lineJohn McCarthy-1/19/2000
754 Hi Craig, The document appears to deliniate rights of each individual party toBRAVEHEART-1/19/2000
753 Dr. John, thanks for sharing the good news. I just received an email from FreeCraig S. Owens-1/19/2000
752 Neuropathic Pain Phase II Clinical Trial is Significant The 40 mg dose was signDr. John M. de Castro-1/19/2000
751 Off Topic ...... Diabetic neuropathy fyi ............ biz.yahoo.com regards,John McCarthy-1/18/2000
750 Hi John, Happy Birthday ...May the gods of Biodom see to it that the P-II resBRAVEHEART-1/12/2000
749 Happy Birthday! May you receive your Birthday wish as it would be a present fVikingWarrior-1/12/2000
748 Craig, we are very very close to hearing. I expect an announcement soon. Today Dr. John M. de Castro-1/12/2000
747 Dr. John, It appears that the excitement of the <b>possibility</b> Craig S. Owens-1/10/2000
746 Dopamine release in the prefrontal cortex in response to memantine following suDr. John M. de Castro-1/5/2000
745 The results of the Phase II trial of memantine for Neuropathic pain should be oDr. John M. de Castro-1/5/2000
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News